HEADER HYDROLASE 03-SEP-08 3EDZ TITLE CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH HYDROXAMATE TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: ADAM 17; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 215-477; COMPND 5 SYNONYM: A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 17, TNF-ALPHA- COMPND 6 CONVERTING ENZYME, TNF-ALPHA CONVERTASE, SNAKE VENOM-LIKE PROTEASE; COMPND 7 EC: 3.4.24.86; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ADAM17, CSVP, TACE; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111 KEYWDS HYDROLASE, ZN-ENDOPEPTIDASE, CLEAVAGE ON PAIR OF BASIC RESIDUES, KEYWDS 2 GLYCOPROTEIN, MEMBRANE, METAL-BINDING, METALLOPROTEASE, NOTCH KEYWDS 3 SIGNALING PATHWAY, PHOSPHOPROTEIN, PROTEASE, SH3-BINDING, KEYWDS 4 TRANSMEMBRANE, ZYMOGEN EXPDTA X-RAY DIFFRACTION AUTHOR R.D.MAZZOLA,Z.ZHU,L.SINNING,B.MCKITTRICK,B.LAVEY,J.SPITLER, AUTHOR 2 J.KOZLOWSKI,S.NENG-YANG,G.ZHOU,Z.GUO,P.ORTH,V.MADISON,J.SUN, AUTHOR 3 D.LUNDELL,X.NIU REVDAT 7 20-OCT-21 3EDZ 1 REMARK SEQADV LINK REVDAT 6 13-JUL-11 3EDZ 1 VERSN REVDAT 5 10-NOV-09 3EDZ 1 JRNL REVDAT 4 23-JUN-09 3EDZ 1 JRNL REVDAT 3 02-JUN-09 3EDZ 1 JRNL REVDAT 2 24-FEB-09 3EDZ 1 VERSN REVDAT 1 23-SEP-08 3EDZ 0 JRNL AUTH R.D.MAZZOLA,Z.ZHU,L.SINNING,B.MCKITTRICK,B.LAVEY,J.SPITLER, JRNL AUTH 2 J.KOZLOWSKI,S.NENG-YANG,G.ZHOU,Z.GUO,P.ORTH,V.MADISON,J.SUN, JRNL AUTH 3 D.LUNDELL,X.NIU JRNL TITL DISCOVERY OF NOVEL HYDROXAMATES AS HIGHLY POTENT TUMOR JRNL TITL 2 NECROSIS FACTOR-ALPHA CONVERTING ENZYME INHIBITORS. PART II: JRNL TITL 3 OPTIMIZATION OF THE S3' POCKET. JRNL REF BIOORG.MED.CHEM.LETT. V. 18 5809 2008 JRNL REFN ISSN 0960-894X JRNL PMID 18835710 JRNL DOI 10.1016/J.BMCL.2008.09.045 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT 2.1.1 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.83 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 84.6 REMARK 3 NUMBER OF REFLECTIONS : 42913 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.174 REMARK 3 R VALUE (WORKING SET) : 0.174 REMARK 3 FREE R VALUE : 0.204 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 1.920 REMARK 3 FREE R VALUE TEST SET COUNT : 823 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 5 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.07 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 84.60 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 8243 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1852 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 8083 REMARK 3 BIN R VALUE (WORKING SET) : 0.1843 REMARK 3 BIN FREE R VALUE : 0.2350 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 1.94 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 160 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4051 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 88 REMARK 3 SOLVENT ATOMS : 428 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 25.29 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.47 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.69016 REMARK 3 B22 (A**2) : 0.50377 REMARK 3 B33 (A**2) : 0.18639 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4247 ; 2.000 ; NULL REMARK 3 BOND ANGLES : 5719 ; 2.000 ; NULL REMARK 3 TORSION ANGLES : 864 ; 0.000 ; NULL REMARK 3 TRIGONAL CARBON PLANES : 134 ; 2.000 ; NULL REMARK 3 GENERAL PLANES : 606 ; 5.000 ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS : 4219 ; 20.000 ; NULL REMARK 3 BAD NON-BONDED CONTACTS : 56 ; 5.000 ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : NULL ; NULL ; NULL REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : NULL ; NULL ; NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.02 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : NULL REMARK 3 OTHER TORSION ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3EDZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-SEP-08. REMARK 100 THE DEPOSITION ID IS D_1000049203. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-AUG-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42913 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.04300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 69.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: PDB ENTRY 1BKC REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.19 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.37 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15% PEG 6000, 10% 2-PROPANOL, 100 MM REMARK 280 SODIUM CITRATE BUFFER, PH 5.6, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 37.39800 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 51.43850 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.85100 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 51.43850 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 37.39800 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.85100 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 215 REMARK 465 ALA A 216 REMARK 465 ASP A 217 REMARK 465 LYS A 476 REMARK 465 VAL A 477 REMARK 465 GLY A 478 REMARK 465 SER A 479 REMARK 465 HIS A 480 REMARK 465 HIS A 481 REMARK 465 HIS A 482 REMARK 465 HIS A 483 REMARK 465 HIS A 484 REMARK 465 HIS A 485 REMARK 465 ARG B 215 REMARK 465 ALA B 216 REMARK 465 ASP B 217 REMARK 465 PRO B 218 REMARK 465 ASP B 219 REMARK 465 SER B 474 REMARK 465 ASN B 475 REMARK 465 LYS B 476 REMARK 465 VAL B 477 REMARK 465 GLY B 478 REMARK 465 SER B 479 REMARK 465 HIS B 480 REMARK 465 HIS B 481 REMARK 465 HIS B 482 REMARK 465 HIS B 483 REMARK 465 HIS B 484 REMARK 465 HIS B 485 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 448 NZ REMARK 470 ARG B 241 CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 270 -117.54 -135.15 REMARK 500 CYS A 365 121.08 73.30 REMARK 500 ASN A 381 57.06 -96.23 REMARK 500 ALA B 270 -105.30 -122.23 REMARK 500 LYS B 273 -169.87 -122.78 REMARK 500 SER B 360 -156.33 -94.50 REMARK 500 CYS B 365 119.61 82.11 REMARK 500 ALA B 424 69.59 -151.27 REMARK 500 SER B 441 -96.03 -119.13 REMARK 500 CYS B 469 -4.31 -143.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 1 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 INN A 2 O REMARK 620 2 INN A 2 O4 78.6 REMARK 620 3 HIS A 405 NE2 101.9 91.7 REMARK 620 4 HIS A 409 NE2 155.0 90.2 100.8 REMARK 620 5 HIS A 415 NE2 86.9 159.3 105.8 97.1 REMARK 620 6 HOH A 648 O 75.0 79.0 170.6 81.0 83.1 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 2 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 550 B 1 O1 REMARK 620 2 550 B 1 O2 72.4 REMARK 620 3 HIS B 405 NE2 110.5 98.7 REMARK 620 4 HIS B 409 NE2 145.8 89.1 100.4 REMARK 620 5 HIS B 415 NE2 92.7 158.8 100.7 95.6 REMARK 620 N 1 2 3 4 REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE ENZYME INHIBITOR REMARK 630 MOLECULE NAME: N-{(2R)-2-[2-(HYDROXYAMINO)-2-OXOETHYL]-4- REMARK 630 METHYLPENTANOYL}-3-METHYL-L-VALYL-N-(2-AMINOETHYL)-L-ALANINAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 INN A 2 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: 2HM TBG ALA EDN REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE INN A 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CIT A 4 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 550 B 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CIT B 3 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1BKC RELATED DB: PDB REMARK 900 CATALYTIC DOMAIN OF TNF-ALPHA CONVERTING ENZYME (TACE) REMARK 900 RELATED ID: 2FV9 RELATED DB: PDB REMARK 900 CRYSTAL STUCTURE OF TACE IN COMPLEX WITH JMV 390-1 REMARK 900 RELATED ID: 2FV5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF TACE IN COMPLEX WITH IK682 DBREF 3EDZ A 215 477 UNP P78536 ADA17_HUMAN 215 477 DBREF 3EDZ B 215 477 UNP P78536 ADA17_HUMAN 215 477 SEQADV 3EDZ ALA A 266 UNP P78536 SER 266 ENGINEERED MUTATION SEQADV 3EDZ GLY A 353 UNP P78536 VAL 353 ENGINEERED MUTATION SEQADV 3EDZ GLN A 452 UNP P78536 ASN 452 ENGINEERED MUTATION SEQADV 3EDZ GLY A 478 UNP P78536 EXPRESSION TAG SEQADV 3EDZ SER A 479 UNP P78536 EXPRESSION TAG SEQADV 3EDZ HIS A 480 UNP P78536 EXPRESSION TAG SEQADV 3EDZ HIS A 481 UNP P78536 EXPRESSION TAG SEQADV 3EDZ HIS A 482 UNP P78536 EXPRESSION TAG SEQADV 3EDZ HIS A 483 UNP P78536 EXPRESSION TAG SEQADV 3EDZ HIS A 484 UNP P78536 EXPRESSION TAG SEQADV 3EDZ HIS A 485 UNP P78536 EXPRESSION TAG SEQADV 3EDZ ALA B 266 UNP P78536 SER 266 ENGINEERED MUTATION SEQADV 3EDZ GLY B 353 UNP P78536 VAL 353 ENGINEERED MUTATION SEQADV 3EDZ GLN B 452 UNP P78536 ASN 452 ENGINEERED MUTATION SEQADV 3EDZ GLY B 478 UNP P78536 EXPRESSION TAG SEQADV 3EDZ SER B 479 UNP P78536 EXPRESSION TAG SEQADV 3EDZ HIS B 480 UNP P78536 EXPRESSION TAG SEQADV 3EDZ HIS B 481 UNP P78536 EXPRESSION TAG SEQADV 3EDZ HIS B 482 UNP P78536 EXPRESSION TAG SEQADV 3EDZ HIS B 483 UNP P78536 EXPRESSION TAG SEQADV 3EDZ HIS B 484 UNP P78536 EXPRESSION TAG SEQADV 3EDZ HIS B 485 UNP P78536 EXPRESSION TAG SEQRES 1 A 271 ARG ALA ASP PRO ASP PRO MET LYS ASN THR CYS LYS LEU SEQRES 2 A 271 LEU VAL VAL ALA ASP HIS ARG PHE TYR ARG TYR MET GLY SEQRES 3 A 271 ARG GLY GLU GLU SER THR THR THR ASN TYR LEU ILE GLU SEQRES 4 A 271 LEU ILE ASP ARG VAL ASP ASP ILE TYR ARG ASN THR ALA SEQRES 5 A 271 TRP ASP ASN ALA GLY PHE LYS GLY TYR GLY ILE GLN ILE SEQRES 6 A 271 GLU GLN ILE ARG ILE LEU LYS SER PRO GLN GLU VAL LYS SEQRES 7 A 271 PRO GLY GLU LYS HIS TYR ASN MET ALA LYS SER TYR PRO SEQRES 8 A 271 ASN GLU GLU LYS ASP ALA TRP ASP VAL LYS MET LEU LEU SEQRES 9 A 271 GLU GLN PHE SER PHE ASP ILE ALA GLU GLU ALA SER LYS SEQRES 10 A 271 VAL CYS LEU ALA HIS LEU PHE THR TYR GLN ASP PHE ASP SEQRES 11 A 271 MET GLY THR LEU GLY LEU ALA TYR GLY GLY SER PRO ARG SEQRES 12 A 271 ALA ASN SER HIS GLY GLY VAL CYS PRO LYS ALA TYR TYR SEQRES 13 A 271 SER PRO VAL GLY LYS LYS ASN ILE TYR LEU ASN SER GLY SEQRES 14 A 271 LEU THR SER THR LYS ASN TYR GLY LYS THR ILE LEU THR SEQRES 15 A 271 LYS GLU ALA ASP LEU VAL THR THR HIS GLU LEU GLY HIS SEQRES 16 A 271 ASN PHE GLY ALA GLU HIS ASP PRO ASP GLY LEU ALA GLU SEQRES 17 A 271 CYS ALA PRO ASN GLU ASP GLN GLY GLY LYS TYR VAL MET SEQRES 18 A 271 TYR PRO ILE ALA VAL SER GLY ASP HIS GLU ASN ASN LYS SEQRES 19 A 271 MET PHE SER GLN CYS SER LYS GLN SER ILE TYR LYS THR SEQRES 20 A 271 ILE GLU SER LYS ALA GLN GLU CYS PHE GLN GLU ARG SER SEQRES 21 A 271 ASN LYS VAL GLY SER HIS HIS HIS HIS HIS HIS SEQRES 1 B 271 ARG ALA ASP PRO ASP PRO MET LYS ASN THR CYS LYS LEU SEQRES 2 B 271 LEU VAL VAL ALA ASP HIS ARG PHE TYR ARG TYR MET GLY SEQRES 3 B 271 ARG GLY GLU GLU SER THR THR THR ASN TYR LEU ILE GLU SEQRES 4 B 271 LEU ILE ASP ARG VAL ASP ASP ILE TYR ARG ASN THR ALA SEQRES 5 B 271 TRP ASP ASN ALA GLY PHE LYS GLY TYR GLY ILE GLN ILE SEQRES 6 B 271 GLU GLN ILE ARG ILE LEU LYS SER PRO GLN GLU VAL LYS SEQRES 7 B 271 PRO GLY GLU LYS HIS TYR ASN MET ALA LYS SER TYR PRO SEQRES 8 B 271 ASN GLU GLU LYS ASP ALA TRP ASP VAL LYS MET LEU LEU SEQRES 9 B 271 GLU GLN PHE SER PHE ASP ILE ALA GLU GLU ALA SER LYS SEQRES 10 B 271 VAL CYS LEU ALA HIS LEU PHE THR TYR GLN ASP PHE ASP SEQRES 11 B 271 MET GLY THR LEU GLY LEU ALA TYR GLY GLY SER PRO ARG SEQRES 12 B 271 ALA ASN SER HIS GLY GLY VAL CYS PRO LYS ALA TYR TYR SEQRES 13 B 271 SER PRO VAL GLY LYS LYS ASN ILE TYR LEU ASN SER GLY SEQRES 14 B 271 LEU THR SER THR LYS ASN TYR GLY LYS THR ILE LEU THR SEQRES 15 B 271 LYS GLU ALA ASP LEU VAL THR THR HIS GLU LEU GLY HIS SEQRES 16 B 271 ASN PHE GLY ALA GLU HIS ASP PRO ASP GLY LEU ALA GLU SEQRES 17 B 271 CYS ALA PRO ASN GLU ASP GLN GLY GLY LYS TYR VAL MET SEQRES 18 B 271 TYR PRO ILE ALA VAL SER GLY ASP HIS GLU ASN ASN LYS SEQRES 19 B 271 MET PHE SER GLN CYS SER LYS GLN SER ILE TYR LYS THR SEQRES 20 B 271 ILE GLU SER LYS ALA GLN GLU CYS PHE GLN GLU ARG SER SEQRES 21 B 271 ASN LYS VAL GLY SER HIS HIS HIS HIS HIS HIS HET ZN A 1 1 HET INN A 2 29 HET CIT A 4 13 HET ZN B 2 1 HET 550 B 1 31 HET CIT B 3 13 HETNAM ZN ZINC ION HETNAM INN N-{(2R)-2-[2-(HYDROXYAMINO)-2-OXOETHYL]-4- HETNAM 2 INN METHYLPENTANOYL}-3-METHYL-L-VALYL-N-(2-AMINOETHYL)-L- HETNAM 3 INN ALANINAMIDE HETNAM CIT CITRIC ACID HETNAM 550 METHYL (1R,2S)-2-(HYDROXYCARBAMOYL)-1-{4-[(2- HETNAM 2 550 METHYLQUINOLIN-4-YL) HETNAM 3 550 METHOXY]BENZYL}CYCLOPROPANECARBOXYLATE FORMUL 3 ZN 2(ZN 2+) FORMUL 4 INN C19 H37 N5 O5 FORMUL 5 CIT 2(C6 H8 O7) FORMUL 7 550 C24 H24 N2 O5 FORMUL 9 HOH *428(H2 O) HELIX 1 1 ASP A 232 MET A 239 1 8 HELIX 2 2 GLU A 243 ASN A 264 1 22 HELIX 3 3 ASP A 313 ILE A 325 1 13 HELIX 4 4 ILE A 325 SER A 330 1 6 HELIX 5 5 PHE A 343 THR A 347 5 5 HELIX 6 6 LEU A 395 GLY A 412 1 18 HELIX 7 7 ASN A 426 GLY A 430 5 5 HELIX 8 8 SER A 451 LYS A 460 1 10 HELIX 9 9 THR A 461 PHE A 470 1 10 HELIX 10 10 ASP B 232 MET B 239 1 8 HELIX 11 11 GLU B 243 ASN B 264 1 22 HELIX 12 12 ASP B 313 ILE B 325 1 13 HELIX 13 13 ILE B 325 SER B 330 1 6 HELIX 14 14 PHE B 343 THR B 347 5 5 HELIX 15 15 LEU B 395 PHE B 411 1 17 HELIX 16 16 ASN B 426 GLY B 430 5 5 HELIX 17 17 HIS B 444 MET B 449 5 6 HELIX 18 18 SER B 451 PHE B 470 1 20 SHEET 1 A 5 GLY A 276 ILE A 284 0 SHEET 2 A 5 THR A 224 ALA A 231 1 N LEU A 227 O GLU A 280 SHEET 3 A 5 LEU A 334 THR A 339 1 O PHE A 338 N VAL A 230 SHEET 4 A 5 SER A 382 SER A 386 1 O THR A 385 N THR A 339 SHEET 5 A 5 GLY A 349 ALA A 351 -1 N LEU A 350 O LEU A 384 SHEET 1 B 2 ALA A 368 SER A 371 0 SHEET 2 B 2 LYS A 376 TYR A 379 -1 O ILE A 378 N TYR A 369 SHEET 1 C 2 LYS A 388 ASN A 389 0 SHEET 2 C 2 LYS A 392 THR A 393 -1 O LYS A 392 N ASN A 389 SHEET 1 D 5 GLY B 276 ILE B 284 0 SHEET 2 D 5 THR B 224 ALA B 231 1 N LEU B 227 O GLU B 280 SHEET 3 D 5 LEU B 334 THR B 339 1 O PHE B 338 N VAL B 230 SHEET 4 D 5 SER B 382 SER B 386 1 O THR B 385 N LEU B 337 SHEET 5 D 5 GLY B 349 ALA B 351 -1 N LEU B 350 O LEU B 384 SHEET 1 E 2 ALA B 368 SER B 371 0 SHEET 2 E 2 LYS B 376 TYR B 379 -1 O ILE B 378 N TYR B 369 SHEET 1 F 2 LYS B 388 ASN B 389 0 SHEET 2 F 2 LYS B 392 THR B 393 -1 O LYS B 392 N ASN B 389 SSBOND 1 CYS A 225 CYS A 333 1555 1555 2.03 SSBOND 2 CYS A 365 CYS A 469 1555 1555 2.03 SSBOND 3 CYS A 423 CYS A 453 1555 1555 2.03 SSBOND 4 CYS B 225 CYS B 333 1555 1555 2.04 SSBOND 5 CYS B 365 CYS B 469 1555 1555 2.03 SSBOND 6 CYS B 423 CYS B 453 1555 1555 2.04 LINK ZN ZN A 1 O INN A 2 1555 1555 2.02 LINK ZN ZN A 1 O4 INN A 2 1555 1555 2.16 LINK ZN ZN A 1 NE2 HIS A 405 1555 1555 1.98 LINK ZN ZN A 1 NE2 HIS A 409 1555 1555 2.09 LINK ZN ZN A 1 NE2 HIS A 415 1555 1555 2.06 LINK ZN ZN A 1 O HOH A 648 1555 1555 2.20 LINK O1 550 B 1 ZN ZN B 2 1555 1555 2.08 LINK O2 550 B 1 ZN ZN B 2 1555 1555 2.07 LINK ZN ZN B 2 NE2 HIS B 405 1555 1555 2.09 LINK ZN ZN B 2 NE2 HIS B 409 1555 1555 2.11 LINK ZN ZN B 2 NE2 HIS B 415 1555 1555 2.05 CISPEP 1 TYR A 304 PRO A 305 0 7.52 CISPEP 2 TYR B 304 PRO B 305 0 5.07 CISPEP 3 SER B 355 PRO B 356 0 6.38 SITE 1 AC1 5 INN A 2 HIS A 405 HIS A 409 HIS A 415 SITE 2 AC1 5 HOH A 648 SITE 1 AC2 22 ZN A 1 GLU A 327 SER A 330 LYS A 331 SITE 2 AC2 22 MET A 345 GLY A 346 THR A 347 LEU A 348 SITE 3 AC2 22 GLY A 349 ASN A 389 TYR A 390 HIS A 405 SITE 4 AC2 22 GLU A 406 HIS A 409 HIS A 415 PRO A 437 SITE 5 AC2 22 ILE A 438 ALA A 439 HOH A 508 HOH A 614 SITE 6 AC2 22 HOH A 648 HOH A 651 SITE 1 AC3 13 GLY A 353 SER A 355 SER A 360 HIS A 361 SITE 2 AC3 13 GLY A 362 LYS A 367 LYS A 465 HOH A 520 SITE 3 AC3 13 HOH A 522 HOH A 529 HOH A 531 HOH A 642 SITE 4 AC3 13 HOH A 664 SITE 1 AC4 4 550 B 1 HIS B 405 HIS B 409 HIS B 415 SITE 1 AC5 18 ZN B 2 GLY B 346 THR B 347 LEU B 348 SITE 2 AC5 18 GLY B 349 LEU B 401 HIS B 405 GLU B 406 SITE 3 AC5 18 HIS B 409 HIS B 415 VAL B 434 TYR B 436 SITE 4 AC5 18 PRO B 437 ALA B 439 VAL B 440 SER B 441 SITE 5 AC5 18 GLY B 442 HOH B 827 SITE 1 AC6 12 PRO A 356 ARG A 357 HIS A 415 PRO A 437 SITE 2 AC6 12 HOH A 650 ARG B 357 ASN B 359 SER B 360 SITE 3 AC6 12 HIS B 361 HOH B 728 HOH B 736 HOH B 857 CRYST1 74.796 75.702 102.877 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013370 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013210 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009720 0.00000